This Pathogen Pulse highlights: Whooping cough, oropouche fever, and avian influenza. Read on to get caught up on the latest.
Pathogen Pulse with Isis Lamphier, MPH, MHA, CIC
This Pathogen Pulse focuses on 3 critical topics shaping public health discussions: Whooping cough, oropouche fever, and avian fevers.
Infectious diseases continue to pose significant public health challenges worldwide. This year, 3 major concerns are grabbing attention: the resurgence of whooping cough, the spread of Oropouche fever, and ongoing global outbreaks of avian influenza. Each disease presents unique risks and complexities, demanding targeted infection control measures.
Whooping Cough
Whooping cough, or pertussis, caused by Bordetella pertussis, has seen a troubling resurgence in several countries, including the US, the UK, and parts of Europe. Despite high vaccination rates, periodic outbreaks persist. In 2024, a notable spike in cases occurred, sparking renewed public health concerns.
“In 2024, reported cases of pertussis increased across the US, indicating a return to more typical trends. Preliminary data show that more than 5 times as many cases have been reported as of week 41, reported on October 12, 2024, compared to the same time in 2023,” according to the CDC.
Several factors contribute to this resurgence:
The current focus is on increasing booster doses in adolescents and adults, improving infant vaccination rates, and ensuring early diagnosis and treatment to prevent severe cases, particularly in vulnerable populations like infants and older persons.
Oropouche Fever
Oropouche fever is an emerging tropical disease caused by the Oropouche virus, a member of the Orthobunyavirus genus. It was previously concentrated in Brazil and Peru, but the disease is now reported in new areas such as Suriname and northern Colombia.
“The Oropouche virus is primarily transmitted to humans through the bite of Culicoides paraensis midges,” according to the World Health Organization. “Culex quinquefasciatus, Coquillettidia venezuelensis, and Aedes serratus mosquitoes can also be vectors. The virus is believed to circulate in both a sylvatic* cycle in forested areas and in an urban epidemic cycle between insects and people. In the sylvatic cycle, nonhuman primates, sloths, and perhaps birds serve as vertebrate hosts, although a definitive arthropod vector has not been identified.”
* “Relating to or denoting certain diseases when contracted by wild animals, and the pathogens causing them.” –Oxford Languages
Oropouche fever typically presents with influenza-like symptoms, including high fever, headache, joint pain, and a rash. While most cases are mild, it can lead to more serious neurological complications, including meningitis and encephalitis in some patients. Because it shares symptoms with other diseases like dengue and Zika, Oropouche fever is often underdiagnosed, making it a growing concern for public health systems in tropical regions. There is currently no vaccine for Oropouche fever, so efforts focus on vector control and public awareness to prevent further spread.
Avian Influenza
Avian influenza, particularly the H5N1 strain, continues to be a persistent global threat affecting poultry industries and human health. The most pressing concern with avian flu is its potential to jump from birds to humans. Although human infections remain rare, the World Health Organization (WHO) has flagged the risk of the virus mutating to become more transmissible between humans.
Efforts to contain the spread of avian influenza include strict biosecurity measures in poultry farms, culling infected flocks, and enhancing vaccination programs for poultry. Monitoring for early signs of cross-species transmission and developing updated vaccines are critical steps in pandemic preparedness for humans. Meanwhile, public health advisories urge avoiding contact with sick or dead birds, thoroughly cooking poultry products, and drinking only pasteurized milk to mitigate infection risks.
The resurgence of whooping cough, the emergence of Oropouche fever, and the persistent threat of avian influenza highlight the dynamic nature of infectious diseases in our globalized world. As new challenges arise, the field of infection control must remain agile, adapting to evolving threats and maintaining preparedness for the next infectious disease threat.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.